Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H32 |
| Molecular Weight | 260.4574 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@]12CCC[C@H]1[C@@H]3CC[C@H]4CCCC[C@]4(C)[C@H]3CC2
InChI
InChIKey=QZLYKIGBANMMBK-UGCZWRCOSA-N
InChI=1S/C19H32/c1-18-11-5-7-16(18)15-9-8-14-6-3-4-12-19(14,2)17(15)10-13-18/h14-17H,3-13H2,1-2H3/t14-,15+,16+,17+,18+,19+/m1/s1
| Molecular Formula | C19H32 |
| Molecular Weight | 260.4574 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. | 2003-07 |
|
| Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand, TCPOBOP. | 2003-06 |
|
| Cloning of a functional vitamin D receptor from the lamprey (Petromyzon marinus), an ancient vertebrate lacking a calcified skeleton and teeth. | 2003-06 |
|
| Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. | 2003-05-09 |
|
| Nuclear receptors orchestrate detoxification pathways. | 2003-05 |
|
| Quantitation of CYP2B6, constitutive androstane receptor, and pregnane X receptor mRNA levels. | 2003-05 |
|
| Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes. | 2003-05 |
|
| Regulation of drug transporter gene expression by nuclear receptors. | 2003-05 |
|
| A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. | 2003-04-18 |
|
| Induction of bilirubin clearance by the constitutive androstane receptor (CAR). | 2003-04-01 |
|
| Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. | 2003-04-01 |
|
| Sequence diversity and functional characterization of the 5'-regulatory region of human CYP2C19. | 2003-04 |
|
| Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-activated receptor gamma coactivator-1 alpha. A possible link between xenobiotic response and nutritional state. | 2003-03-28 |
|
| Repression of farnesoid X receptor during the acute phase response. | 2003-03-14 |
|
| Use of dominant negative nuclear receptors to study xenobiotic-inducible gene expression in primary cultured hepatocytes. | 2003-03-12 |
|
| Assessment of porcine and human 16-ene-synthase, a third activity of P450c17, in the formation of an androstenol precursor. Role of recombinant cytochrome b5 and P450 reductase. | 2003-03 |
|
| Predicting inductive drug-drug interactions. | 2003-03 |
|
| Transcriptional analysis in vivo of the hepatic genes, Cyp2b9 and Cyp2b10, by intravenous administration of plasmid DNA in mice. | 2003-02-17 |
|
| The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. | 2003-02-17 |
|
| Phenobarbital induction of drug/steroid-metabolizing enzymes and nuclear receptor CAR. | 2003-02-17 |
|
| Functional and structural comparison of PXR and CAR. | 2003-02-17 |
|
| Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors. | 2003-02-17 |
|
| Homology modelling of the nuclear receptors: human oestrogen receptorbeta (hERbeta), the human pregnane-X-receptor (PXR), the Ah receptor (AhR) and the constitutive androstane receptor (CAR) ligand binding domains from the human oestrogen receptor alpha (hERalpha) crystal structure, and the human peroxisome proliferator activated receptor alpha (PPARalpha) ligand binding domain from the human PPARgamma crystal structure. | 2003-02 |
|
| The critical role of carboxy-terminal amino acids in ligand-dependent and -independent transactivation of the constitutive androstane receptor. | 2003-02 |
|
| The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. | 2003-02 |
|
| The role of the nuclear receptor CAR as a coordinate regulator of hepatic gene expression in defense against chemical toxicity. | 2003-01-01 |
|
| Comparative urinary androstanes in the great apes. | 2003-01 |
|
| Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element. | 2003-01 |
|
| Constitutive androstane receptor and pregnane X receptor gene expression in human liver: interindividual variability and correlation with CYP2B6 mRNA levels. | 2003-01 |
|
| In vivo activation of the constitutive androstane receptor beta (CARbeta) by treatment with dehydroepiandrosterone (DHEA) or DHEA sulfate (DHEA-S). | 2002-12-18 |
|
| A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta. | 2002-12 |
|
| Synthesis and neuromuscular blocking activity of 16beta-N-methylpiperazino steroidal derivatives. | 2002-11 |
|
| Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor. | 2002-11 |
|
| Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. | 2002-10-21 |
|
| Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. | 2002-10-11 |
|
| Toxicology. Protecting liver from painkiller's lethal dose. | 2002-10-11 |
|
| Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. | 2002-10 |
|
| Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. | 2002-09 |
|
| Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. | 2002-09 |
|
| Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element. | 2002-09 |
|
| Insights from a three-dimensional model into ligand binding to constitutive active receptor. | 2002-09 |
|
| A genome-wide linkage scan for steroids and SHBG levels in black and white families: the HERITAGE Family Study. | 2002-08 |
|
| Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes. | 2002-08 |
|
| Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. | 2002-08 |
|
| Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. | 2002-08 |
|
| Receptor-mediated hepatocarcinogenesis: role of hepatocyte proliferation and apoptosis. | 2002-07 |
|
| [The role of nuclear receptors in cytochrome P-450 induction by xenochemicals]. | 2002 |
|
| [Investigation of neuromuscular blocking agents at Richter Ltd]. | 2002 |
|
| Direct expression of fluorescent protein-tagged nuclear receptor CAR in mouse liver. | 2002 |
|
| [Progress in the study of orphan nuclear receptor]. | 2001-04 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:04:14 GMT 2025
by
admin
on
Mon Mar 31 22:04:14 GMT 2025
|
| Record UNII |
KT649U81FE
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
28859
Created by
admin on Mon Mar 31 22:04:14 GMT 2025 , Edited by admin on Mon Mar 31 22:04:14 GMT 2025
|
PRIMARY | |||
|
DTXSID2036532
Created by
admin on Mon Mar 31 22:04:14 GMT 2025 , Edited by admin on Mon Mar 31 22:04:14 GMT 2025
|
PRIMARY | |||
|
49000
Created by
admin on Mon Mar 31 22:04:14 GMT 2025 , Edited by admin on Mon Mar 31 22:04:14 GMT 2025
|
PRIMARY | |||
|
438-22-2
Created by
admin on Mon Mar 31 22:04:14 GMT 2025 , Edited by admin on Mon Mar 31 22:04:14 GMT 2025
|
PRIMARY | |||
|
94144
Created by
admin on Mon Mar 31 22:04:14 GMT 2025 , Edited by admin on Mon Mar 31 22:04:14 GMT 2025
|
PRIMARY | |||
|
KT649U81FE
Created by
admin on Mon Mar 31 22:04:14 GMT 2025 , Edited by admin on Mon Mar 31 22:04:14 GMT 2025
|
PRIMARY | |||
|
Androstane
Created by
admin on Mon Mar 31 22:04:14 GMT 2025 , Edited by admin on Mon Mar 31 22:04:14 GMT 2025
|
PRIMARY | |||
|
207-116-2
Created by
admin on Mon Mar 31 22:04:14 GMT 2025 , Edited by admin on Mon Mar 31 22:04:14 GMT 2025
|
PRIMARY | |||
|
100000174169
Created by
admin on Mon Mar 31 22:04:14 GMT 2025 , Edited by admin on Mon Mar 31 22:04:14 GMT 2025
|
PRIMARY | |||
|
35509
Created by
admin on Mon Mar 31 22:04:14 GMT 2025 , Edited by admin on Mon Mar 31 22:04:14 GMT 2025
|
PRIMARY | |||
|
m1898
Created by
admin on Mon Mar 31 22:04:14 GMT 2025 , Edited by admin on Mon Mar 31 22:04:14 GMT 2025
|
PRIMARY | Merck Index |